Sunday 
 
 
2:00 pm - 9:00 pm 
	
Arrival and Check-in
 
 
						
6:00 pm - 7:00 pm 
	
Dinner
 
 
						
7:30 pm - 7:40 pm 
	
Introductory Comments by GRC Site Staff / Welcome from the GRC Chair
 
 
						
7:40 pm - 9:30 pm 
	
Keynote Session: Quantitative Extrapolations of Transporters and Drug Metabolizing Enzymes 
 
 
 
						
7:40 pm - 7:55 pm 
	
Opening Remarks
 
 
						
7:55 pm - 8:55 pm 
	
"A Quantification Identity Crisis for DMPK and ADME-Exploring Advances in Quantitative Predictions of Drug Metabolism, Transport, Safety and Pharmacokinetics" 
 
 
 
						
8:55 pm - 9:30 pm 
	
Discussion
 
 
						
	Monday 
 
 
7:30 am - 8:30 am 
	
Breakfast
 
 
						
8:30 am - 9:00 am 
	
Group Photo
 
 
						
9:00 am - 12:30 pm 
	
Quantitative Predictions for Non-P450 Mechanisms 
 
 
 
						
9:00 am - 9:05 am 
	
Introduction by Discussion Leader
 
 
						
9:05 am - 9:30 am 
	
"Role of Sulfotransferases in Metabolic Activation" 
 
 
 
						
9:30 am - 9:45 am 
	
Discussion
 
 
						
9:45 am - 10:15 am 
	
"Sulfotransferases in Liver Disease" 
 
 
 
						
10:15 am - 10:30 am 
	
Discussion
 
 
						
10:30 am - 11:00 am 
	
Coffee Break
 
 
						
11:00 am - 11:30 am 
	
"Modeling the In Vivo  Balance Between Phase I and Phase II Metabolism" 
 
 
 
						
11:30 am - 11:45 am 
	
Discussion
 
 
						
11:45 am - 12:15 pm 
	
"Sulfatase Inhibitors: From Concept to Clinic and Beyond" 
 
 
 
						
12:15 pm - 12:30 pm 
	
Discussion
 
 
						
12:30 pm - 1:30 pm 
	
Lunch
 
 
						
1:30 pm - 4:00 pm 
	
Free Time
 
 
						
4:00 pm - 6:00 pm 
	
Poster Session 
 
 
						
6:00 pm - 7:00 pm 
	
Dinner
 
 
						
7:30 pm - 9:30 pm 
	
Antibody/ADC Biophysics Considerations in Predicting
Human Disposition 
 
 
 
						
7:30 pm - 7:35 pm 
	
Introduction by Discussion Leader
 
 
						
7:35 pm - 7:55 pm 
	
"Binding Affinity of LM to FcRn and Its Importance in Disposition of Large Molecules" 
 
 
 
						
7:55 pm - 8:10 pm 
	
Discussion
 
 
						
8:10 pm - 8:35 pm 
	
"Understanding Localization of Biotherapeutics at Whole body, Tissue and Cellular Level in Preclinical Development" 
 
 
 
						
8:35 pm - 8:50 pm 
	
Discussion
 
 
						
8:50 pm - 9:15 pm 
	
"Physiologically-Relevant Kd Measurements to Inform PK-PD Modeling" 
 
 
 
						
9:15 pm - 9:30 pm 
	
Discussion
 
 
						
	Tuesday 
 
 
7:30 am - 8:30 am 
	
Breakfast
 
 
						
9:00 am - 12:30 pm 
	
Safety Considerations in Clinical Drug Metabolism and Transport 
 
 
 
						
9:00 am - 9:05 am 
	
Introduction by Discussion Leader
 
 
						
9:05 am - 9:30 am 
	
"Pharmacokinetics, Efficacy and Safety in Drug-Drug Interactions: Do They Go Hand in Hand?" 
 
 
 
						
9:30 am - 9:45 am 
	
Discussion
 
 
						
9:45 am - 10:15 am 
	
"Understanding Complex Perpetrator DDIs Involving Hepatic/Gut Transporters and Their Interplay with CYP3A Enzymes: From In Vitro  to Mechanistic Clinical Evaluations" 
 
 
 
						
10:15 am - 10:30 am 
	
Discussion
 
 
						
10:30 am - 11:00 am 
	
Coffee Break
 
 
						
11:00 am - 11:30 am 
	
"Thiamine Transporters: Emerging Mechanisms of Drug Toxicity and Disposition" 
 
 
 
						
11:30 am - 11:45 am 
	
Discussion
 
 
						
11:45 am - 12:15 pm 
	
"Identification of Natural Products as Precipitants of Clinical Drug Interactions: Challenges and Opportunities" 
 
 
 
						
12:15 pm - 12:30 pm 
	
Discussion
 
 
						
12:30 pm - 1:30 pm 
	
Lunch
 
 
						
1:30 pm - 4:00 pm 
	
Free Time
 
 
						
4:00 pm - 6:00 pm 
	
Poster Session 
 
 
						
6:00 pm - 7:00 pm 
	
Dinner
 
 
						
7:30 pm - 9:30 pm 
	
Challenging Michaelis-Menten Drug Metabolism 
and Transport Kinetics 
 
 
 
						
7:30 pm - 7:35 pm 
	
Introduction by Discussion Leader
 
 
						
7:35 pm - 7:55 pm 
	
"Using Numerical Approaches to Model Complex CYP Kinetics" 
 
 
 
						
7:55 pm - 8:10 pm 
	
Discussion
 
 
						
8:10 pm - 8:35 pm 
	
"Atypical Kinetics of UDP-Glucuronosyltransferases: The Problem of Determining Accurate In Vitro  Clearances" 
 
 
 
						
8:35 pm - 8:50 pm 
	
Discussion
 
 
						
8:50 pm - 9:15 pm 
	
"Atypical Kinetics in Drug Transporters: Theoretical and Practical Considerations" 
 
 
 
						
9:15 pm - 9:30 pm 
	
Discussion
 
 
						
	Wednesday 
 
 
7:30 am - 8:30 am 
	
Breakfast
 
 
						
9:00 am - 12:30 pm 
	
Quantitative Understanding of Fraction Metabolized: Newer Challenges in Scaling and Predictivity 
 
 
 
						
9:00 am - 9:05 am 
	
Introduction by Discussion Leader
 
 
						
9:05 am - 9:35 am 
	
"Evaluating In Vivo  Esterase-Mediated Drug Metabolism: Should Be Easy, but Why Do We Fail?" 
 
 
 
						
9:35 am - 9:50 am 
	
Discussion
 
 
						
9:50 am - 10:15 am 
	
"The Combination of Bottom-Up and Top-Down Modelling Approaches to Predict In Vivo  Hepatic Uptake Clearance and Tissue Partitioning" 
 
 
 
						
10:15 am - 10:30 am 
	
Discussion
 
 
						
10:30 am - 11:00 am 
	
Coffee Break
 
 
						
11:00 am - 11:30 am 
	
"Role of Quantitative Proteomics Data to Predict Fraction Metabolized by Non-CYP Enzymes" 
 
 
 
						
11:30 am - 11:45 am 
	
Discussion
 
 
						
11:45 am - 12:15 pm 
	
"ECM-Based IVIVE Method for the Prediction of Human Clearance and Relative Elimination Pathway Contributions" 
 
 
 
						
12:15 pm - 12:30 pm 
	
Discussion
 
 
						
12:30 pm - 1:30 pm 
	
Lunch
 
 
						
1:30 pm - 4:00 pm 
	
Free Time
 
 
						
4:00 pm - 6:00 pm 
	
Poster Session 
 
 
						
6:00 pm - 7:00 pm 
	
Dinner
 
 
						
7:00 pm - 7:30 pm 
	
Business Meeting 
Nominations for the Next Vice Chair; Fill in Conference Evaluation Forms; Discuss Future Site and Scheduling Preferences; Election of the Next Vice Chair 
 
 
						
7:30 pm - 9:30 pm 
	
Young Investigator Presentations 
Six poster abstracts from trainees will be highlighted with short oral presentations. 
 
 
 
						
7:30 pm - 7:45 pm 
	
"Formation and Distribution of Cis- and Trans-Epoxyeicosatrienoic Acids in Patients with Cardiovascular Disease" 
 
 
 
						
7:45 pm - 7:50 pm 
	
Discussion
 
 
						
7:50 pm - 8:05 pm 
	
"Treatment of Hepatocellular Carcinoma HepG2 Cells with β-Naphthoflavone Simultaneously Increased Intracellular and Exosomal Expression of CYP1A1" 
 
 
 
						
8:05 pm - 8:10 pm 
	
Discussion
 
 
						
8:10 pm - 8:25 pm 
	
"Identification of Molecular Determinants Involved in the Transport and Metabolism of Kinase Inhibitors in Prostate Cancer Cells" 
 
 
 
						
8:25 pm - 8:30 pm 
	
Discussion
 
 
						
8:30 pm - 8:45 pm 
	
"Time-Dependent Inhibition of Cytochrome P450 3A4 by Itraconazole and Metabolites" 
 
 
 
						
8:45 pm - 8:50 pm 
	
Discussion
 
 
						
8:50 pm - 9:05 pm 
	
"Comparison of Different Tissue:Plasma Water Partition Coefficient Models and Their Ability to Predict the Steady-State Volume of Distribution and the Concentration-Time Profiles in Humans" 
 
 
 
						
9:05 pm - 9:10 pm 
	
Discussion
 
 
						
9:10 pm - 9:25 pm 
	
"Genetic Variation, Age, and Gender Are Associated with Human Liver UGT2B17 Protein Abundance and Activity" 
 
 
 
						
9:25 pm - 9:30 pm 
	
Discussion
 
 
						
	Thursday 
 
 
7:30 am - 8:30 am 
	
Breakfast
 
 
						
9:00 am - 12:30 pm 
	
Emerging Technologies in Predicting Extrahepatic Metabolism and Toxicity 
 
 
 
						
9:00 am - 9:05 am 
	
Introduction by Discussion Leader
 
 
						
9:05 am - 9:30 am 
	
"Translational Applications of the Human Physiome on a Chip" 
 
 
 
						
9:30 am - 9:45 am 
	
Discussion
 
 
						
9:45 am - 10:15 am 
	
"	A Three-Dimensional Bioprinted Model of the Renal Proximal Tubule for Evaluation of Drug-Induced Nephrotoxicity" 
 
 
 
						
10:15 am - 10:30 am 
	
Discussion
 
 
						
10:30 am - 11:00 am 
	
Coffee Break
 
 
						
11:00 am - 11:30 am 
	
"Microphysiological Organ Systems for Drug Discovery, Disease Modeling, Personalized Medicine" 
 
 
 
						
11:30 am - 11:45 am 
	
Discussion
 
 
						
11:45 am - 12:15 pm 
	
"Ancestral Sequence Reconstruction of P450s: the 'Retro' Approach to Understanding Drug Metabolism" 
 
 
 
						
12:15 pm - 12:30 pm 
	
Discussion
 
 
						
12:30 pm - 1:30 pm 
	
Lunch
 
 
						
1:30 pm - 4:00 pm 
	
Free Time
 
 
						
4:00 pm - 6:00 pm 
	
Poster Session 
 
 
						
6:00 pm - 7:00 pm 
	
Dinner
 
 
						
7:30 pm - 9:30 pm 
	
Advances and Challenges in Predicting Human PK Profiles 
 
 
 
						
7:30 pm - 7:35 pm 
	
Introduction by Discussion Leader
 
 
						
7:35 pm - 8:00 pm 
	
"Physiologically-Based Pharmacokinetic (PBPK) Modeling Predictions for Entry into Human (EIH) Studies: An Analysis of Small Molecule Development Candidates at Hoffmann-LaRoche, 2003-2015" 
 
 
 
						
8:00 pm - 8:10 pm 
	
Discussion
 
 
						
8:10 pm - 8:35 pm 
	
"Assessment of Dose, Intrinsic Pharmacokinetics, and Efficacious Steady-State Concentration of 368 Oral Drugs" 
 
 
 
						
8:35 pm - 8:45 pm 
	
Discussion
 
 
						
8:45 pm - 9:10 pm 
	
"Early
PK Predictions to Enable Rational and Efficient Drug Design" 
 
 
 
						
9:10 pm - 9:20 pm 
	
Discussion
 
 
						
9:20 pm - 9:30 pm 
	
Closing Remarks
 
 
						
	Friday 
 
 
7:30 am - 8:30 am 
	
Breakfast
 
 
						
9:00 am 
	
Departure